You may be an excellent candidate if you: Are noticing fine lines, wrinkles, or skin laxity and want to address the root cause rather than just the surface appearance Have photodamaged skin from years of sun exposure in Ponte Vedra Beach's sunny coastal climate Want to improve skin firmness and density without surgical intervention Are looking for a complement to aesthetic treatments like fillers, Botox, or microneedling that accelerates results and longevity Are interested in preventive anti-aging beginning GHK-Cu therapy before significant visible aging occurs is one of the most effective long-term strategies Want to optimize healing after a skin procedure or experience generally dull, tired-looking skin Are a peptide therapy patient already on a protocol like Sermorelin or BPC-157 and want to add a skin-specific component GHK-Cu is not typically appropriate for pregnant or breastfeeding patients, and as with all peptide therapies, a consultation with our provider is the appropriate first step
S2CID 23075151
Disclaimer: This blog has been written exclusively for educational purposes
F.HastieN
Clinical trials, including phase 2 and 3 studies, have reported significant improvements in liver histology, including MASH resolution and decreased hepatic fat content, with GLP-1RA therapy (6, 7)
Drug interactions: metformin Carbonic anhydrase inhibitors (acetazolamide, zonisamide) Drugs reducing metformin clearance (cimetidine, dolutegravir, ranolazine, vandetanib) Alcohol (risk of lactic acidosis) How they work together Januvia increases incretin levels to boost insulin release and lower glucagon, while metformin reduces hepatic glucose output and improves insulin sensitivity
